Cardinal Health

According to a recent report, Goldman Sachs hosted a dinner with Cardinal Health (NYSE: CAH) CFO Jeff Henderson at the 32nd Annual Global Healthcare Conference. The tones of the dinner was positive and CAH internal initiatives seem to be back on track. Additional highlights of the conference...

JP Morgan has raised the price target on Cardinal Health (NYSE: CAH) from $44 to $48 and maintains its Overweight rating.

J.P. Morgan has released an update on Cardinal Health (NYSE: CAH) before its conference call tomorrow. In the report J.P. Morgan writes, "Acute-care distribution is the largest business within the medical segment, and we estimate it represents roughly 75% of segment revenue. Cardinal has 32%...

In a report published by J.P. Morgan, Cardinal Health (NYSE: CAH) is taking a deeper look at Yong Yu. J.P. Morgan said that this morning, it is launching a series of reports as part of Cardinal Week, which will run through Thursday, with today's focus on Cardinal Health's recent acquisition of...

Deutsche Bank has issued a company alert on Cardinal Health (NYSE: CAH) after the company's 2Q far exceeded analyst estimates. In the report, Deutsche Bank writes "CAH reported FY2Q'11 EPS of $0.69, well above our EPS estimate of $0.63 and the Reuter's consensus estimate of $0.61. CAH also reported...

Among the distributors, J.P. Morgan said that it favors McKesson Corporation (NYSE: MCK) and Cardinal Health, Inc. (NYSE: CAH). “We continue to believe that MCK is underappreciated, as the distribution business continues to successfully expand generic penetration and EBIT growth continues to be the...

Morgan Stanley has updated its model to incorporate Cardinal Health, Inc.'s (NYSE: CAH) Kinray and Yong Yu acquisitions. “For FY11, we now forecast non-GAAP EPS of $2.52 (from $2.50) and cash EPS of $2.58,vs. consensus' $2.51 and management's guidance range of $2.38-2.48, which excludes strategic...

J.P. Morgan released its report on Cardinal Health (NYSE: CAH) following CAH's investment day. In a note to clients, J.P. Morgan writes, "Yong Yu and Kinray acquisitions increase EPS growth trajectory. Management expects the Yong Yu acquisition to open opportunities beyond pharmaceuticals, such as...

Morgan Stanley makes the following revisions this morning: Upgrades Dominion Resources (NYSE: D) from Underweight to Equal-weight. Price target increases from $41.75 to $42.75. Downgrades Embotelladora Andina (NYSE: AKO) from Overweight to Equal-weight. Entergy Corp. (NYSE: ETR) from Overweight to...

Citi reiterates its Hold rating on Cardinal Health (NYSE: CAH) following CAH's investor day. In a note to clients, Citi writes, "Management expects FY2010-FY2015 non-GAAP EPS growth >10%, with LT total shareholder returns >11% (incl. dividends). FY11 non GAAP guidance of $2.38-$2.48...